Avenue Therapeutics Statistics
Total Valuation
ATXI has a market cap or net worth of $3.25 million. The enterprise value is $52,402.
| Market Cap | 3.25M |
| Enterprise Value | 52,402 |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ATXI has 940,986 shares outstanding. The number of shares has increased by 657.47% in one year.
| Shares Outstanding | 940,986 |
| Shares Change (YoY) | +657.47% |
| Shares Change (QoQ) | +297.98% |
| Owned by Insiders (%) | 1.90% |
| Owned by Institutions (%) | 1.99% |
| Float | 871,522 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 17.99 |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.14 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.34, with zero debt.
| Current Ratio | 2.34 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -392.00% |
| Return on Capital (ROIC) | -416.71% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.39M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.07% in the last 52 weeks. The beta is -0.20, so ATXI's price volatility has been lower than the market average.
| Beta (5Y) | -0.20 |
| 52-Week Price Change | -96.07% |
| 50-Day Moving Average | 3.61 |
| 200-Day Moving Average | 12.80 |
| Relative Strength Index (RSI) | 42.97 |
| Average Volume (20 Days) | 30,382 |
Short Selling Information
The latest short interest is 39,249, so 4.17% of the outstanding shares have been sold short.
| Short Interest | 39,249 |
| Short Previous Month | 42,441 |
| Short % of Shares Out | 4.17% |
| Short % of Float | 4.50% |
| Short Ratio (days to cover) | 1.65 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.82M |
| Pretax Income | -7.18M |
| Net Income | -7.18M |
| EBITDA | -7.18M |
| EBIT | -7.18M |
| Earnings Per Share (EPS) | -$7.90 |
Balance Sheet
The company has $3.19 million in cash and no debt, giving a net cash position of $3.19 million or $3.39 per share.
| Cash & Cash Equivalents | 3.19M |
| Total Debt | n/a |
| Net Cash | 3.19M |
| Net Cash Per Share | $3.39 |
| Equity (Book Value) | 2.84M |
| Book Value Per Share | 3.01 |
| Working Capital | 1.90M |
Cash Flow
| Operating Cash Flow | -11.00M |
| Capital Expenditures | n/a |
| Free Cash Flow | -11.00M |
| FCF Per Share | -$19.57 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATXI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -657.47% |
| Shareholder Yield | -657.47% |
| Earnings Yield | -221.20% |
| FCF Yield | -338.78% |
Analyst Forecast
The average price target for ATXI is $56.25, which is 1,530.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $56.25 |
| Price Target Difference | 1,530.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 26, 2024. It was a reverse split with a ratio of 1:75.
| Last Split Date | Apr 26, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:75 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |